Nigel Chen‐Tan
Impact in
- Building and Construction top 5%
- Recycling and utilization of industrial and municipal waste in materials production
-
- Concrete and Cement Materials Research
- Innovative concrete reinforcement materials
Papers in
-
- Advanced Drug Delivery Systems 5
- Drug Solubulity and Delivery Systems 3
- Surgery 4
- Pancreatic function and diabetes 4
- Co-authors
- Arie van Riessen (4 shared papers)Hani Al‐Salami (9 shared papers)Daniel Southam (1 shared paper)Frank Arfuso (7 shared papers)Jadambaa Temuujin (1 shared paper)A. Minjigmaa (1 shared paper)Armin Mooranian (6 shared papers)Rebecca Negrulj (6 shared papers)
- Journals
- Artificial Cells Nanomedicine and Biotechnology (3 papers)Journal of the American Ceramic Society (2 papers)Fuel (2 papers)Microbial Drug Resistance (1 paper)Drug Design Development and Therapy (1 paper)
- Partner nations
- AustraliaMontenegroSerbia
In The Last Decade
Nigel Chen‐Tan
18 papers receiving 802 citations
Peers
Comparison fields: 5 of 87
- Building and Construction 214
- Civil and Structural Engineering 341
- Pharmaceutical Science 86
- Pharmacology 81
- Endocrinology, Diabetes and Metabolism 78
Countries citing papers authored by Nigel Chen‐Tan
This map shows the geographic impact of Nigel Chen‐Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Chen‐Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Chen‐Tan more than expected).
Fields of papers citing papers by Nigel Chen‐Tan
This network shows the impact of papers produced by Nigel Chen‐Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Chen‐Tan. The network helps show where Nigel Chen‐Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Nigel Chen‐Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 153 | |
| 2 | 2011 | 150 | |
| 3 | 2014 | 60 | |
| 4 | 2014 | 59 | |
| 5 | 2014 | 52 | |
| 6 | 2015 | 51 | |
| 7 | 2014 | 50 | |
| 8 | 2016 | 44 | |
| 9 | 2012 | 32 | |
| 10 | 2015 | 30 | |
| 11 | 2015 | 30 | |
| 12 | 2013 | 28 | |
| 13 | 2014 | 21 | |
| 14 | 2011 | 19 | |
| 15 | 2019 | 13 | |
| 16 | Novel multicompartmental bile acid-based microcapsules for pancreatic β-cell transplantation | 2015 | 10 |
| 17 | 2018 | 7 | |
| 18 | 2006 | 7 |
About Nigel Chen‐Tan
Nigel Chen‐Tan is a scholar working on Pharmaceutical Science, Surgery, Civil and Structural Engineering, Materials Chemistry and Pharmacology, having authored 18 papers that have together received 816 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (5 papers), Concrete and Cement Materials Research (4 papers), Pancreatic function and diabetes (4 papers), Drug Solubulity and Delivery Systems (3 papers), Cannabis and Cannabinoid Research (3 papers), Recycling and utilization of industrial and municipal waste in materials production (3 papers), Diabetes Management and Research (2 papers) and Clay minerals and soil interactions (1 paper). The work is most often cited by research in Building and Construction (214 citations), Civil and Structural Engineering (341 citations), Pharmaceutical Science (86 citations), Pharmacology (81 citations) and Endocrinology, Diabetes and Metabolism (78 citations). Nigel Chen‐Tan has collaborated with scholars based in Australia, Montenegro and Serbia. Frequent co-authors include Arie van Riessen, Hani Al‐Salami, Daniel Southam, Frank Arfuso, Jadambaa Temuujin, A. Minjigmaa, Armin Mooranian, Rebecca Negrulj, Momir Mikov and Svetlana Goločorbin-Kon. Their work appears in journals such as Artificial Cells Nanomedicine and Biotechnology, Journal of the American Ceramic Society, Fuel, Microbial Drug Resistance and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.